Drug Safety Surveillance and Epidemiology

June 04, 2008

Drug Information Association, Four Points by Sheraton, Washington DC, USA Sep 8 2008 This course is designed to provide an overview of US and international safety surveillance, including the role of epidemiology and risk management, from both industry and FDA perspectives. This overview is not a “how to” course in completing adverse event forms for regulatory reporting. •The role of epidemiology in safety surveillance •Domestic and international safety surveillance •Regulatory and industry perspectives on safety surveillance and epidemiology.

Organized by:			Drug Information Association
Invited Speakers:			Steven J. Blumenthal, MSAssociate Director, Safety Update ReportingMerck Research LaboratoriesUnited States Linda S HostelleyVice President, Worldwide Product Safety and Quality AssuranceMerck & Co., Inc.United States Judith M Sills, PharmDVice President & Head of Medical Safety OperationsNovartis Pharmaceuticals CorporationUnited States I. Sanford Smith, MDUnited States Annette Stemhagen, Dr PH, FISPEVice President, Epidemiology and Risk ManagementUnited Biosource CorporationUnited States.

Deadline for Abstracts:			Sep 8 2008

Registration:			http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16082&eventType=Training%20Course
E-mail:			dia@diahome.org

events